Streetbeat News

Revenues

LRE

Lead Real Estate has announced the sale of a 17-unit luxury condominium in Tokyo. The financial details of the transaction were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 1:37 pm

JAGX

Napo Pharmaceuticals, part of Jaguar Health, Inc. (NASDAQ:JAGX), announced the availability of an abstract on a Quality of Life survey for cancer patients on the SABCS website. The survey, supported by Napo, highlights the challenges faced by breast cancer patients and survivors, emphasizing the decline in QoL post-cancer. Key concerns include fatigue, muscle/joint pain, and emotional distress. The survey also reveals a lack of preparedness for treatment side effects. Additionally, Jaguar's Phase 3 OnTarget trial for cancer therapy-related diarrhea (CTD) will be presented at SABCS, with results for the drug crofelemer pending.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 1:36 pm

WBUY

Webuy Global Ltd (NASDAQ:WBUY) has announced a non-binding MOU to acquire a 51% stake in PT. Tiga Sakti Utama (TSU), an Indonesian fruit importer and wholesaler. The deal involves an exchange of 800,000 Webuy shares for the equity interest, with a lockup arrangement. TSU, profitable since 2021, generated $15 million in sales in 2022. The acquisition aims to expand Webuy's presence in Indonesia and Southeast Asia, leveraging Surabaya's strategic location. A definitive agreement is expected by mid-2024, subject to due diligence and closing conditions.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 1:33 pm

SPY

U.S. exports for October amounted to $258.80 billion, a slight decrease from the previous figure of $261.10 billion.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 1:32 pm

S

SentinelOne, Inc. (NYSE:S) shares surged over 18% in pre-market trading following the release of their Q3 results, which exceeded analyst expectations. The company reported $164.2 million in revenue, surpassing the $156.09 million estimate, and an adjusted loss of 3 cents per share, better than the expected 8 cents per share loss. SentinelOne also increased its full-year 2024 revenue forecast from $605 million to $616 million.

Portfolio Pulse from Lisa Levin

December 06, 2023 | 1:32 pm

SPY

The United States has imported goods worth $323.00 billion, a slight increase from the prior value of $322.70 billion.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 1:32 pm

ODFL

Old Dominion Freight Line Inc (NASDAQ:ODFL) reported a 0.9% Y/Y decline in revenue per day for November 2023, driven by a 2.3% drop in LTL tons per day, despite higher LTL revenue per hundredweight. The decrease in LTL tons per day was due to a 2.9% decline in LTL weight per shipment. Quarter-to-date, LTL revenue per hundredweight was up 3.1%, and excluding fuel surcharges, up 7.6%. The company attributes the revenue decrease to a soft domestic economy but notes improvement in yield metrics and a slight increase in LTL shipments per day. In Q3 FY23, revenue fell 5.5% Y/Y to $1.515 billion, slightly below consensus, while EPS of $3.09 exceeded expectations. ODFL shares closed down 2.16% at $394.79 on Tuesday.

Portfolio Pulse from Lekha Gupta

December 06, 2023 | 1:16 pm

DAL

Delta Air Lines reported a strong operational performance during the 10-day Thanksgiving period, with over 50,000 flights and fewer than 20 cancellations.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 1:13 pm

ORA

Ormat Technologies, Inc. (NYSE:ORA) has signed a 25-year Power Purchase Agreement with Dominica Electricity Services Ltd. for a 10 MW geothermal power plant in Dominica, expected to be operational by 2025. The project aligns with Ormat's growth plans and will utilize operational synergies with its Bouillante power plant in Guadeloupe. The development will increase Ormat's Caribbean capacity to 35 MW and support regional transition from fossil fuels. Ownership of the plant will transfer to the Dominica government at the end of the term.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 1:13 pm

AWH

Aspira Women's Health Inc. (AWH) has completed the design of EndoCheck, a blood test for localized endometriosis, and plans a commercial launch in 2024. The test shows promise as a non-invasive alternative to laparoscopic surgery for diagnosing endometriomas. Aspira is collaborating with The University of Oxford and The Dana Farber Cancer Institute for validation and research. The company is also developing EndoMDx for broader endometriosis indications and is in talks with potential partners to drive shareholder value. An Analyst Day event is scheduled for January 2024.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 1:08 pm